No Data
No Data
Trending Stocks Today | MasterBeef Shoots up 65.31% Post-Market
Biodexa Pharmaceuticals | 20-F: FY2024 Annual Report
Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | Biodexa Pharmaceuticals Expects Initiation Of Phase 3 Registrational Study Of ERapa In FAP, Initiation Of IIT Of Tolimidone In T1D At University Of Alberta As 2025 Clinical Milestones
ADRs Close Higher; Biodexa Pharmaceuticals PLC Climbs 16%
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading